Allergan Under Investigation By Oregon For Deceptive Promotions
This article was originally published in The Pink Sheet Daily
Executive Summary
State effort is focused on one unnamed drug but may expand; the company is already facing a federal inquiry about off-label promotion of Botox for headache treatment.